CoChat

Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial

Bonomo, M., Corica, D., Mion, E., Gonçalves, D., Motta, G., Merati, R., Ragusa, A., Morabito, A. · 2005 · Diabetic Medicine
Cited by 93

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims Most studies relating minor gestational metabolic alterations to macrosomia refer to glucose intolerance classified on the basis of the National Diabetes Data Group or previous World Health Organization diagnostic thresholds. Our aim was to evaluate the consequences of very mild forms of gestational glucose intolerance, defined by an elevated 50‐g glucose challenge test followed by a normal oral glucose tolerance test, using the more restrictive Carpenter and Coustan's criteria (Borderline Gestational Glucose Intolerance, BGGI). Methods Three hundred BGGI women were randomly assigned to: Group A (standard management), Group B (dietary treatment and regular monitoring). A control group (C) was also considered. Newborns were classified as macrosomic, large (LGA), or small for gestational age (SGA). Results The three groups were similar in age, body mass index and parity. Therapy in Group B significantly improved fasting (from 4.68 ± 0.45 to 4.28 ± 0.45 mmol/l) and 2‐h postprandial glycaemia (from 6.01 ± 0.57 to 5.13 ± 0.68 mmol/l). Fasting glycaemia at delivery was significantly lower in B (4.20 ± 0.38 mmol/l) than in A (4.84 ± 0.45 mmol/l), and was also lower than in C (4.31 ± 0.39 mmol/l). Significantly fewer LGA babies were born to Group B (6.0%) than Group A (14.0%) and Group C (9.1%). No difference was found in the SGA rate. The neonatal Ponderal Index was higher (P = 0.030) in group A (2.73 ± 0.35) than in C (2.64 ± 0.30) and B (2.64 ± 0.24). Conclusions Even very mild alterations in glucose tolerance can result in excessive or disharmonious fetal growth, which may be prevented by simple, non‐invasive therapeutic measures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2005.01690.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 4 references

Cited by

See all 93

Metadata

Authors
Bonomo, M., Corica, D., Mion, E., Gonçalves, D., Motta, G., Merati, R., Ragusa, A., & Morabito, A.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2005-10-19
Volume
22
Issue
11
Pages
1536-1541
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2107602842
Cited by
93
References
4
FWCI
3.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial. https://app.cochat.ai/papers/10.1111/j.1464-5491.2005.01690.x
The paper
Bonomo, M., Corica, D., Mion, E., Gonçalves, D., Motta, G., Merati, R., Ragusa, A., & Morabito, A. (2005). Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2005.01690.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.